In summary, this study provides compelling evidence that DOE alleviates cancer cachexia-induced muscle atrophy and lipolysis in both cells and cachectic CT26-bearing mice through the activation of the PI3K/AKT signaling pathway. The gene discussed is AKT1; the disease is cancer.